協和キリンの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/05/11 | 3,400 | 3,400 | 3,295 | 3,320 | -55 | -1.6% | 749,600 |
| 2021/05/10 | 3,365 | 3,435 | 3,335 | 3,375 | +25 | +0.7% | 973,000 |
| 2021/05/07 | 3,485 | 3,495 | 3,335 | 3,350 | -125 | -3.6% | 1,654,500 |
| 2021/05/06 | 3,420 | 3,490 | 3,395 | 3,475 | +155 | +4.7% | 1,711,600 |
| 2021/04/30 | 3,300 | 3,375 | 3,295 | 3,320 | +30 | +0.9% | 1,122,500 |
| 2021/04/28 | 3,310 | 3,330 | 3,280 | 3,290 | ±0 | ±0% | 731,600 |
| 2021/04/27 | 3,315 | 3,325 | 3,250 | 3,290 | -30 | -0.9% | 701,900 |
| 2021/04/26 | 3,310 | 3,365 | 3,290 | 3,320 | -10 | -0.3% | 733,100 |
| 2021/04/23 | 3,340 | 3,375 | 3,220 | 3,330 | -10 | -0.3% | 742,100 |
| 2021/04/22 | 3,275 | 3,345 | 3,275 | 3,340 | +110 | +3.4% | 630,300 |
| 2021/04/21 | 3,255 | 3,300 | 3,220 | 3,230 | -35 | -1.1% | 801,300 |
| 2021/04/20 | 3,355 | 3,355 | 3,250 | 3,265 | -90 | -2.7% | 805,700 |
| 2021/04/19 | 3,315 | 3,380 | 3,290 | 3,355 | +55 | +1.7% | 1,010,300 |
| 2021/04/16 | 3,295 | 3,320 | 3,280 | 3,300 | +15 | +0.5% | 590,200 |
| 2021/04/15 | 3,310 | 3,325 | 3,260 | 3,285 | -20 | -0.6% | 388,000 |
| 2021/04/14 | 3,290 | 3,315 | 3,265 | 3,305 | -5 | -0.2% | 513,200 |
| 2021/04/13 | 3,290 | 3,340 | 3,285 | 3,310 | +35 | +1.1% | 514,100 |
| 2021/04/12 | 3,290 | 3,305 | 3,250 | 3,275 | -5 | -0.2% | 449,600 |
| 2021/04/09 | 3,315 | 3,365 | 3,280 | 3,280 | -5 | -0.2% | 1,117,500 |
| 2021/04/08 | 3,290 | 3,310 | 3,220 | 3,285 | +35 | +1.1% | 715,600 |
| 2021/04/07 | 3,275 | 3,290 | 3,215 | 3,250 | -55 | -1.7% | 1,381,000 |
| 2021/04/06 | 3,350 | 3,370 | 3,300 | 3,305 | -45 | -1.3% | 694,600 |
| 2021/04/05 | 3,370 | 3,395 | 3,320 | 3,350 | +20 | +0.6% | 620,700 |
| 2021/04/02 | 3,280 | 3,335 | 3,260 | 3,330 | ±0 | ±0% | 604,300 |
| 2021/04/01 | 3,350 | 3,365 | 3,305 | 3,330 | +20 | +0.6% | 848,100 |
| 2021/03/31 | 3,260 | 3,335 | 3,240 | 3,310 | +35 | +1.1% | 938,600 |
| 2021/03/30 | 3,345 | 3,350 | 3,260 | 3,275 | ±0 | ±0% | 658,100 |
| 2021/03/29 | 3,330 | 3,330 | 3,230 | 3,275 | -5 | -0.2% | 1,017,700 |
| 2021/03/26 | 3,215 | 3,305 | 3,185 | 3,280 | +110 | +3.5% | 984,200 |
| 2021/03/25 | 3,150 | 3,190 | 3,130 | 3,170 | +50 | +1.6% | 767,900 |
| 2021/03/24 | 3,125 | 3,160 | 3,095 | 3,120 | -25 | -0.8% | 1,059,600 |
| 2021/03/23 | 3,180 | 3,190 | 3,120 | 3,145 | -55 | -1.7% | 1,016,500 |
| 2021/03/22 | 3,195 | 3,225 | 3,175 | 3,200 | -20 | -0.6% | 634,400 |
| 2021/03/19 | 3,180 | 3,245 | 3,180 | 3,220 | +40 | +1.3% | 1,658,700 |
| 2021/03/18 | 3,120 | 3,200 | 3,120 | 3,180 | +65 | +2.1% | 887,800 |
| 2021/03/17 | 3,100 | 3,120 | 3,085 | 3,115 | -35 | -1.1% | 1,082,100 |
| 2021/03/16 | 3,175 | 3,195 | 3,130 | 3,150 | -70 | -2.2% | 1,134,100 |
| 2021/03/15 | 3,195 | 3,225 | 3,160 | 3,220 | +20 | +0.6% | 666,200 |
| 2021/03/12 | 3,195 | 3,210 | 3,155 | 3,200 | +25 | +0.8% | 1,429,300 |
| 2021/03/11 | 3,195 | 3,210 | 3,155 | 3,175 | -25 | -0.8% | 1,002,900 |
| 2021/03/10 | 3,200 | 3,230 | 3,155 | 3,200 | -20 | -0.6% | 877,400 |
| 2021/03/09 | 3,300 | 3,300 | 3,195 | 3,220 | -20 | -0.6% | 961,600 |
| 2021/03/08 | 3,225 | 3,285 | 3,190 | 3,240 | +75 | +2.4% | 682,700 |
| 2021/03/05 | 3,195 | 3,230 | 3,125 | 3,165 | -15 | -0.5% | 947,700 |
| 2021/03/04 | 3,135 | 3,230 | 3,115 | 3,180 | +45 | +1.4% | 1,504,700 |
| 2021/03/03 | 3,025 | 3,140 | 2,980 | 3,135 | +187 | +6.3% | 1,912,000 |
| 2021/03/02 | 2,920 | 2,960 | 2,879 | 2,948 | -2 | -0.1% | 1,232,700 |
| 2021/03/01 | 2,999 | 3,015 | 2,918 | 2,950 | -18 | -0.6% | 844,600 |
| 2021/02/26 | 3,020 | 3,025 | 2,930 | 2,968 | -67 | -2.2% | 1,291,800 |
| 2021/02/25 | 3,150 | 3,150 | 3,020 | 3,035 | -45 | -1.5% | 1,002,900 |
1051～
1100
件表示中 / 3767件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 協和キリン | 263,000円 | -3.5% | -11.3% | 2.28% | 24.16倍 | 1.64倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| アステラス薬 | 167,700円 | +0.9% | +380.2% | 4.65% | 23.10倍 | 1.99倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 259,800円 | +20.9% | +10.6% | 2.54% | 12.28倍 | 1.62倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| エーザイ | 463,500円 | +0.1% | -3.4% | 3.45% | 31.51倍 | 1.55倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 小野薬 | 166,500円 | +0.6% | +43.3% | 4.80% | 11.68倍 | 1.00倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
